These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 23333526)

  • 41. Prognostic value of hepatic venous pressure gradient in patients with compensated chronic hepatitis C-related cirrhosis.
    Rincón D; Lo Iacono O; Tejedor M; Hernando A; Ripoll C; Catalina MV; Salcedo M; Matilla A; Senosiain M; Clemente G; Molinero LM; Albillos A; Bañares R
    Scand J Gastroenterol; 2013 Apr; 48(4):487-95. PubMed ID: 22871085
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The predictive value of serum laminin for the risk of variceal bleeding related to portal pressure levels.
    Kondo M; Miszputen SJ; Leite-mor MM; Parise ER
    Hepatogastroenterology; 1995; 42(5):542-5. PubMed ID: 8751212
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The diagnostic significance of soluble CD163 and soluble interleukin-2 receptor alpha-chain in macrophage activation syndrome and untreated new-onset systemic juvenile idiopathic arthritis.
    Bleesing J; Prada A; Siegel DM; Villanueva J; Olson J; Ilowite NT; Brunner HI; Griffin T; Graham TB; Sherry DD; Passo MH; Ramanan AV; Filipovich A; Grom AA
    Arthritis Rheum; 2007 Mar; 56(3):965-71. PubMed ID: 17328073
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Preterm delivery predicted by soluble CD163 and CRP in women with symptoms of preterm delivery.
    Vogel I; Grove J; Thorsen P; Moestrup SK; Uldbjerg N; Møller HJ
    BJOG; 2005 Jun; 112(6):737-42. PubMed ID: 15924529
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prognosis in patients with cirrhosis and mild portal hypertension.
    Ytting H; Møller S; Henriksen JH; Larsen K; Bendtsen F
    Scand J Gastroenterol; 2006 Dec; 41(12):1446-53. PubMed ID: 17101576
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Human monocyte CD163 expression inversely correlates with soluble CD163 plasma levels.
    Davis BH; Zarev PV
    Cytometry B Clin Cytom; 2005 Jan; 63(1):16-22. PubMed ID: 15624200
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical significance of worsening portal hypertension during long-term medical treatment in patients with cirrhosis who had been classified as early good-responders on haemodynamic criteria.
    Merkel C; Bolognesi M; Berzigotti A; Amodio P; Cavasin L; Casarotto IM; Zoli M; Gatta A
    J Hepatol; 2010 Jan; 52(1):45-53. PubMed ID: 19914730
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prediction of Large Esophageal Variceal Bleeding and Subsequent Mortality.
    Soga K; Kassai K; Konishi H; Yagi N; Itani K; Kokura S; Naito Y; Yoshikawa T
    Hepatogastroenterology; 2014 May; 61(131):678-82. PubMed ID: 26176056
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Role of the von Willebrand factor and the VITRO score as predictors for variceal bleeding in patients with hepatitis C-related cirrhosis.
    Ibrahim EH; Marzouk SA; Zeid AE; Lashen SA; Taher TM
    Eur J Gastroenterol Hepatol; 2019 Feb; 31(2):241-247. PubMed ID: 30281535
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Relative adrenal insufficiency in severe acute variceal and non-variceal bleeding: influence on outcomes.
    Graupera I; Pavel O; Hernandez-Gea V; Ardevol A; Webb S; Urgell E; Colomo A; Llaó J; Concepción M; Villanueva C
    Liver Int; 2015 Aug; 35(8):1964-73. PubMed ID: 25644679
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hemorheology in patients with liver cirrhosis: special emphasis on its relation to severity of esophageal variceal bleeding.
    Liu TT; Wong WJ; Hou MC; Lin HC; Chang FY; Lee SD
    J Gastroenterol Hepatol; 2006 May; 21(5):908-13. PubMed ID: 16704544
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Plasma level of the macrophage-derived soluble CD163 is increased and positively correlates with severity in Gaucher's disease.
    Møller HJ; de Fost M; Aerts H; Hollak C; Moestrup SK
    Eur J Haematol; 2004 Feb; 72(2):135-9. PubMed ID: 14962251
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Serum macrophage migration inhibitory factor is an early marker of pancreatic necrosis in acute pancreatitis.
    Rahman SH; Menon KV; Holmfield JH; McMahon MJ; Guillou JP
    Ann Surg; 2007 Feb; 245(2):282-9. PubMed ID: 17245183
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Soluble CD163 in young sickle cell disease patients and their trait siblings: a biomarker for pulmonary hypertension and vaso-occlusive complications.
    Tantawy AA; Adly AA; Ismail EA
    Blood Coagul Fibrinolysis; 2012 Oct; 23(7):640-8. PubMed ID: 22885767
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Soluble CD163 and soluble mannose receptor predict survival and decompensation in patients with liver cirrhosis, and correlate with gut permeability and bacterial translocation.
    Rainer F; Horvath A; Sandahl TD; Leber B; Schmerboeck B; Blesl A; Groselj-Strele A; Stauber RE; Fickert P; Stiegler P; Møller HJ; Grønbaek H; Stadlbauer V
    Aliment Pharmacol Ther; 2018 Mar; 47(5):657-664. PubMed ID: 29266346
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Association of CD163+ macrophages and local production of soluble CD163 with decreased lymphocyte activation in spondylarthropathy synovitis.
    Baeten D; Møller HJ; Delanghe J; Veys EM; Moestrup SK; De Keyser F
    Arthritis Rheum; 2004 May; 50(5):1611-23. PubMed ID: 15146432
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Emergency sclerotherapy in esophageal varices bleeding: prospective study in unselected patients with portal hypertension].
    Szczepanik AB; Misiak A; Meissner AJ
    Pol Merkur Lekarski; 2007 May; 22(131):354-6. PubMed ID: 17679366
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Variceal recurrence, rebleeding, and survival after endoscopic injection sclerotherapy in 287 alcoholic cirrhotic patients with bleeding esophageal varices.
    Krige JE; Kotze UK; Bornman PC; Shaw JM; Klipin M
    Ann Surg; 2006 Nov; 244(5):764-70. PubMed ID: 17060770
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Impact of soluble TWEAK and CD163/TWEAK ratio on long-term cardiovascular mortality in patients with peripheral arterial disease.
    Urbonaviciene G; Martin-Ventura JL; Lindholt JS; Urbonavicius S; Moreno JA; Egido J; Blanco-Colio LM
    Atherosclerosis; 2011 Dec; 219(2):892-9. PubMed ID: 21962403
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Serum soluble CD163 levels in patients with influenza-associated encephalopathy.
    Hasegawa S; Matsushige T; Inoue H; Takahara M; Kajimoto M; Momonaka H; Ishida C; Tanaka S; Morishima T; Ichiyama T
    Brain Dev; 2013 Aug; 35(7):626-9. PubMed ID: 23149357
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.